Safety evaluation of leflunomide in rheumatoid arthritis

The safety of leflunomide

(2016) Sateesh Shankaranarayana et al.   Australian Prescriber

The SMILE Study -- Safety of Methotrexate in Combination with Leflunomide in Rheumatoid Arthritis

(2013) P. BIRD et al.   JOURNAL OF RHEUMATOLOGY

Pregnancy outcome in women exposed to leflunomide before or during pregnancy

(2012) M. Cassina et al.   ARTHRITIS AND RHEUMATISM

Leflunomide in dialysis patients with rheumatoid arthritis—a pharmacokinetic study

(2012) Raoul Bergner et al.   CLINICAL RHEUMATOLOGY

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Leflunomide in psoriatic arthritis: Results from a large European prospective observational study

(2012) Frank Behrens et al.   ARTHRITIS CARE & RESEARCH

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

(2010) J. L. Nam et al.   ANNALS OF THE RHEUMATIC DISEASES

Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review

(2010) Gabrielle van der Velde et al.   ARTHRITIS CARE & RESEARCH

Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis

(2009) T. Sato et al.   RHEUMATOLOGY

Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis

(2009) T. Sawada et al.   RHEUMATOLOGY

Clinical expression of leflunomide-induced pneumonitis

(2009) B. Chikura et al.   RHEUMATOLOGY

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients

(2008) Petra Bohanec Grabar et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY